Efficacy and Safety of IVM/ALB Co-administration

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

1,673

Participants

Timeline

Start Date

September 9, 2018

Primary Completion Date

May 15, 2020

Study Completion Date

July 15, 2020

Conditions
Trichuriasis
Interventions
DRUG

Albendazole

Monotherapy of albendazole (400 mg)

DRUG

Albendazole and Ivermectin

Combination therapy of albendazole (400 mg) and ivermectin (200 µg/kg)

Trial Locations (3)

Unknown

Centre Suisse de Recherches Scientifiques en Côte d'Ivoire (CSRS), Abidjan

Lao Tropical and Public Health Institute, Vientiane

Public Health Laboratory Ivo de Carneri, P.O. Box 122, Chake Chake

All Listed Sponsors
collaborator

Centre Suisse de Recherches Scientifiques en Cote d'Ivoire

OTHER

collaborator

Lao Tropical and Public Health Institute

OTHER_GOV

collaborator

Public Health Laboratory of Pemba, Tanzania

OTHER

lead

Jennifer Keiser

OTHER

NCT03527732 - Efficacy and Safety of IVM/ALB Co-administration | Biotech Hunter | Biotech Hunter